World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
12361
World Ranking
14346
National Ranking
6043

Overview

Fei Chen is affiliated with Stony Brook University in the United States and specializes within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research portfolio includes a significant focus on Molecular Biology, Surgery, Genetics, Neurology, and Oncology as primary subfields of study.

The scientist's main research topics encompass RNA modifications and cancer, RNA research and splicing, liver physiology and pathology, neurological disease mechanisms and treatments, gut microbiota and health, RNA and protein synthesis mechanisms, and neurogenetic and muscular disorders research.

Fei Chen has published extensively in several scholarly venues. Notable recurring publication outlets include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Food Chemistry
  • Nature Communications
  • eLife
  • Frontiers in Neurology

Among recent published papers, several exemplify the scope of Fei Chen's work:

  • "Using arterial-venous analysis to characterize cancer metabolic consumption in patients," 2020, Nature Communications
  • "Ellagic acid blocks RANKL-RANK interaction and suppresses RANKL-induced osteoclastogenesis by inhibiting RANK signaling pathways," 2020, Chemico-Biological Interactions
  • "Clinical application of medical exome sequencing for prenatal diagnosis of fetal structural anomalies," 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology
  • "Effect and mechanism of functional compound fruit drink on gut microbiota in constipation mice," 2022, Food Chemistry
  • "Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer," 2021, Aging

Fei Chen frequently collaborates with a consistent set of coauthors. These include Woo-Ping Ge, Xiaofei Gao, Wenzhi Sun, Jun-Liszt Li, and Yijie Feng, with collaboration counts ranging from three to five joint works.

Best Publications

  • Targeting cancer stem cell pathways for cancer therapy

    Liqun Yang;Pengfei Shi;Gaichao Zhao;Jie Xu

  • New Insights into the Role of Nuclear Factor-κB, a Ubiquitous Transcription Factor in the Initiation of Diseases

    Fei Chen;Vince Castranova;Xianglin Shi;Laurence M. Demers

  • New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation

    Fei Chen;Vince Castranova;Xianglin Shi

  • Diseases caused by silica: mechanisms of injury and disease development

    Min Ding;Fei Chen;Xianglin Shi;Berran Yucesoy

  • JNK-induced apoptosis, compensatory growth, and cancer stem cells

    Fei Chen

  • Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

    Alison P. Klein;Brian M. Wolpin;Harvey A. Risch;Rachael Z. Stolzenberg-Solomon

  • Reactive Oxygen Species (ROS), Troublemakers between Nuclear Factor-κB (NF-κB) and c-Jun NH2-terminal Kinase (JNK)

    Yadong Zhang;Fei Chen

  • Antiproliferative effect of β-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase

    X. Li;G. Wang;J. Zhao;H. Ding

  • The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation.

    Liying Wang;Neelam Azad;Lalana Kongkaneramit;Fei Chen

  • Antioxidant properties of aspirin: Characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-κB activation, and TNF-α production

    Xianglin Shi;Min Ding;Zigang Dong;Fei Chen

  • Intracellular signal transduction of cells in response to carcinogenic metals

    Fei Chen;Xianglin Shi

  • Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer

    Qingshan Chang;Yadong Zhang;Kevin J. Beezhold;Kevin J. Beezhold;Deepak Bhatia

  • Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

    Eva P. Szymanski;Janice M. Leung;Cedar J. Fowler;Carissa Haney

  • Reactive Oxygen Species-Activated Akt/ASK1/p38 Signaling Pathway in Nickel Compound-Induced Apoptosis in BEAS 2B Cells

    Jingju Pan;Qingshan Chang;Xin Wang;Youngok Son

  • miR-190-Mediated Downregulation of PHLPP Contributes to Arsenic-Induced Akt Activation and Carcinogenesis

    Kevin Beezhold;Jia Liu;Jia Liu;Hong Kan;Terry Meighan

  • Cell apoptosis induced by carcinogenic metals

    Fei Chen;Val Vallyathan;Vince Castranova;Xianglin Shi

  • Freshly fractured crystalline silica induces activator protein-1 activation through ERKs and p38 MAPK.

    Min Ding;Xianglin Shi;Zigang Dong;Fei Chen

  • Opposite Effect of NF-κB and c-Jun N-terminal Kinase on p53-independent GADD45 Induction by Arsenite

    Fei Chen;Yongju Lu;Zhuo Zhang;Val Vallyathan

  • NADPH Oxidase Activation Is Required in Reactive Oxygen Species Generation and Cell Transformation Induced by Hexavalent Chromium

    Xin Wang;Young Ok Son;Qingshan Chang;Lijuan Sun

  • Connections between metabolism and epigenetics in cancers.

    Chitra Thakur;Fei Chen

Frequent Co-Authors

Xianglin Shi
Xianglin Shi University of Kentucky
Vince Castranova
Vince Castranova West Virginia University
Val Vallyathan
Val Vallyathan National Institute for Occupational Safety and Health
Min Ding
Min Ding National Institute for Occupational Safety and Health
Zhuo Zhang
Zhuo Zhang University of Kentucky
Stephen S. Leonard
Stephen S. Leonard National Institute for Occupational Safety and Health
Yon Rojanasakul
Yon Rojanasakul West Virginia University
Vincent Castranova
Vincent Castranova West Virginia University
Liying Wang
Liying Wang National Institute for Occupational Safety and Health
Laurence M. Demers
Laurence M. Demers Pennsylvania State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Fei Chen

Trending Scientists

Recently Published Articles